Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2006 1
2007 1
2008 1
2010 5
2011 1
2012 9
2013 9
2014 2
2015 8
2016 5
2017 8
2018 5
2019 3
2020 12
2021 9
2022 7
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Drug Repositioning for Ovarian Cancer Treatment: An Update.
Cavalluzzi MM, Viale M, Rotondo NP, Ferraro V, Lentini G. Cavalluzzi MM, et al. Among authors: lentini g. Anticancer Agents Med Chem. 2024 Feb 1. doi: 10.2174/0118715206282904240122063914. Online ahead of print. Anticancer Agents Med Chem. 2024. PMID: 38367265
Antipsychotics: 70 Years.
Lentini G, Mignani S. Lentini G, et al. Biomedicines. 2023 Nov 16;11(11):3070. doi: 10.3390/biomedicines11113070. Biomedicines. 2023. PMID: 38002069 Free PMC article.
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels.
Farinato A, Cavalluzzi MM, Altamura C, Campanale C, Laghetti P, Saltarella I, Delre P, Barbault A, Tarantino N, Milani G, Rotondo NP, Di Cesare Mannelli L, Ghelardini C, Pierno S, Mangiatordi GF, Lentini G, Desaphy JF. Farinato A, et al. Among authors: lentini g. ACS Med Chem Lett. 2023 Jun 23;14(7):999-1008. doi: 10.1021/acsmedchemlett.3c00224. eCollection 2023 Jul 13. ACS Med Chem Lett. 2023. PMID: 37465302
hERG stereoselective modulation by mexiletine-derived ureas: Molecular docking study, synthesis, and biological evaluation.
Milani G, Budriesi R, Tavazzani E, Cavalluzzi MM, Mattioli LB, Miniero DV, Delre P, Belviso BD, Denegri M, Cuocci C, Rotondo NP, De Palma A, Gualdani R, Caliandro R, Mangiatordi GF, Kumawat A, Camilloni C, Priori S, Lentini G. Milani G, et al. Among authors: lentini g. Arch Pharm (Weinheim). 2023 Oct;356(10):e2300116. doi: 10.1002/ardp.202300116. Epub 2023 Jul 17. Arch Pharm (Weinheim). 2023. PMID: 37460390 Free article.
Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
Todisco S, Musio B, Pesce V, Cavalluzzi MM, Petrosillo G, La Piana G, Sgobba MN, Schlosserová N, Cafferati Beltrame L, Di Lorenzo R, Tragni V, Marzulli D, Guerra L, De Grassi A, Gallo V, Volpicella M, Palese LL, Lentini G, Pierri CL. Todisco S, et al. Among authors: lentini g. Biochem Pharmacol. 2023 Feb;208:115405. doi: 10.1016/j.bcp.2022.115405. Epub 2023 Jan 2. Biochem Pharmacol. 2023. PMID: 36603686 Review.
Unexpected impairment of INa underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome.
Porta-Sánchez A, Mazzanti A, Tarifa C, Kukavica D, Trancuccio A, Mohsin M, Zanfrini E, Perota A, Duchi R, Hernandez-Lopez K, Jáuregui-Abularach ME, Pergola V, Fernandez E, Bongianino R, Tavazzani E, Gambelli P, Memmi M, Scacchi S, Pavarino LF, Franzone PC, Lentini G, Filgueiras-Rama D, Galli C, Santiago DJ, Priori SG. Porta-Sánchez A, et al. Among authors: lentini g. Nat Cardiovasc Res. 2023;2(12):1291-1309. doi: 10.1038/s44161-023-00393-w. Epub 2023 Dec 11. Nat Cardiovasc Res. 2023. PMID: 38665938 Free PMC article.
89 results